Group-sequential methods for adaptive seamless phase II/III clinical trials

Journal of Biopharmaceutical Statistics

Volumn 21, Issue 4, 2011, Pages 787-801

  Stallard, Nigel ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Adaptive designs; Adaptive seamless designs; Early stopping; Interim analyses; Treatment selection

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL DECISION MAKING; CONTROL GROUP; EXPERIMENTAL STUDY; HUMAN; INTERMETHOD COMPARISON; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; STUDY DESIGN;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DATA INTERPRETATION, STATISTICAL; EARLY TERMINATION OF CLINICAL TRIALS; ENDPOINT DETERMINATION; MODELS, STATISTICAL; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 79957511863     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2011.551335     Document Type: Article

References (42)

1. Armitage, P., McPherson, C. K., Rowe, B. C. (1969). Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A 132:235-244.
2. Bauer, P., Kieser, M. (1999). Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 18:1833-1848. (Pubitemid 29364054)
3. Bauer, P., Köhne, K. (1994). Evaluation of experiments with adaptive interim analyses. Biometrics 51:1315-1324.
4. Brannath, W., Bauer, P., Posch, M. (2006). On the efficiency of adaptive designs for flexible interim decisions in clinical trials. Journal of Statistical Planning and Inference 136:1956-1961. (Pubitemid 43193559)
5. Bretz, F., Koenig, F., Brannath, W., Glimm, E., Posch, M. (2009). Adaptive designs for confirmatory clinical trials. Statistics in Medicine 28:1181-1217
6. Bretz, F., Schmidli, H., König, F., Racine, A., Maurer, W. (2006). Confirmatory seamless Phase II/III clinical trials with hypotheses selection at interim: general concepts. Biometrical Journal 48:623-634. (Pubitemid 44367905)
7. Buzuaianu, E. M., Chen, P. (2009). A hybrid selection and testing procedure with curtailment for comparative clinical trials. Sequential Analysis 28:2-20.
8. Chataway, J., Nicholas, R., Todd, S., Miller, D. H., Parsons, N., Valdés-Márquez, E., Stallard, N., Friede, T. (2010). A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis. Multiple Sclerosis 17:81-88.
9. Cheung, Y. (2008). Simple sequential boundaries for treatment selection in multi-armed randomized clinical trials with a control. Biometrics 64:940-949.
10. Dunnett, C. W. (1955). A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association 50:1096-1121.
11. Engel, B., Walstra, P. (1991). Increasing precision or reducing expense in regression experiments by using information from a concomitant variable. Biometrics 47:13-20.
12. Food Drug Administration. (2010). Draft Guidance on Adaptive Design Clinical Trials for Drugs and Biologics. U.S. Food and Drug Administration.
13. Galbraith, S., Marschner, I. C. (2003). Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. Statistics in Medicine 22:1787-1805. (Pubitemid 36603554)
14. Hsu, J. C. (1996). Multiple Comparisons: Theory and Methods. London: Chapman and Hall.
15. Hwang, I. K., Shih, W. J., de Cani, J. S. (1990). Group sequential designs using a family of type I error probability spending functions. Statistics in Medicine 9:1439-1445.
16. Jennison, C., Turnbull, B. W. (1997). Group-sequential analysis incorporating covariate information. Journal of the American Statistical Association 92:1330-1341.
17. Jennison, C., Turnbull, B. W. (2000). Group Sequential Methods with Applications to Clinical Trials. London: Chapman & Hall.
18. Jennison, C., Turnbull, B. W. (2006a). Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations. Biometrical Journal 48:650-655. (Pubitemid 44367908)
19. Jennison, C., Turnbull, B. W. (2006b). Adaptive and nonadaptive group sequential tests. Biometrika 93:1-21.
20. Kelly, P. J., Sooriyarachchi, R. M., Stallard, N., Todd, S. (2005). A practical comparison of group-sequential and adaptive designs. Journal of Biopharmaceutical Statistics 15:719-738. (Pubitemid 40967311)
21. Kim, K., DeMets, D. L. (1987). Design and analysis of group sequential tests based on the type I error spending rate function. Biometrika 74:149-154.
22. Lan, K. K. G., DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika 70:659-663.
23. Lehmacher, W., Wassmer, G. (1999). Adaptive sample size calculations in group sequential tests. Biometrics 55:1286-1290.
24. Liu, Q., Pledger, G. W. (2005). Phase 2 and 3 combination designs to accelerate drug development. Journal of the American Statistical Association 100:493-502. (Pubitemid 40816587)
25. Miller, R. G. (1981). Simultaneous Statistical Inference. New York: Springer-Verlag.
26. Müller, H.-H., Schäfer, H. (2001). Adaptive group sequential designs for clinical trials: combining the advantages of the adaptive and of classical group sequential approaches. Biometrics 57:886-891. (Pubitemid 32801186)
27. Müller, H.-H., Schäfer, H. (2004). A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine 23:2497-2508. (Pubitemid 39149263)
28. O'Brien, P. C., Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics 35:549-556. (Pubitemid 10242750)
29. Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika 64:191-199. (Pubitemid 8145484)
30. Schaid, D. J., Wieand, S., Therneau, T. M. (1990). Optimal two-stage screening designs for survival comparisons. Biometrika 77:507-513.
31. Siegmud, D. (1985). Sequential Analysis. New York: Springer.
32. Stallard, N. (2010). A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information. Statistics in Medicine 29:959-971.
33. Stallard, N., Facey, K. M. (1996). Comparison of the spending function method and the Christmas tree correction for group sequential trials. Journal of Biopharmaceutical Statistics 6:361-373. (Pubitemid 26268471)
34. Stallard, N., Friede, T. (2008). Flexible group-sequential designs for clinical trials with treatment selection. Statistics in Medicine 27:6209-6227.
35. Stallard, N., Todd, S. (2003). Sequential designs for phase III clinical trials incorporating treatment selection. Statistics in Medicine 22:689-703. (Pubitemid 36266961)
36. Thall, P. F., Simon, R., Ellenberg, S. S. (1989). A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics 45:537-547. (Pubitemid 19165264)
37. Tsiatis, A. A., Mehta, C. (2003). On the efficiency of the adaptive design for monitoring clinical trials. Biometrika 90:367-378. (Pubitemid 39047164)
38. Todd, S., Stallard, N. (2005). A new clinical trial design combining phases II and III: Sequential designs with treatment selection and a change of endpoint. Drug Information Journal 39:109-118. (Pubitemid 40647117)
39. van Houwelingen, H. C., Arends, L. R., Stijnen, T. (2002). Advanced methods in metaanalysis: multivariate approach and meta-regression. Statistics in Medicine 21:589-624. (Pubitemid 34141379)
40. Wald, A. (1947). Sequential Analysis. New York: Wiley.
41. Whitehead, J. (1997). The Design and Analysis of Sequential Clinical Trials. Chichester: Wiley.
42. Wilkinson, D., Murray, J. (2001). Galantamine: A randomized, double-blind, dose comparison in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry 16:852-857. (Pubitemid 32926767)